Target intelligence / Profile preview

RNA, U6 small nuclear 297, pseudogene (RNU6-297P)

Target
RNU6-297P
Molecular classification
Other, Small nuclear RNA pseudogene
01

Overview

RNU6-297P refers to a **pseudogene copy of the U6 small nuclear RNA gene**. U6 small nuclear RNA (snRNA) is an essential component of the major spliceosome, the ribonucleoprotein complex that catalyzes pre-mRNA splicing in eukaryotes[1]. The U6 snRNA is highly conserved and critical for RNA processing; however, **RNU6-297P is classified as a pseudogene**, meaning it is a non-functional genomic copy. Pseudogenes like RNU6-297P arise from retrotransposition processes and do not encode a functional RNA. They are not considered therapeutic targets, receptors, enzymes, or any direct functional molecule in cell biology. Rather, such pseudogenes can be used as **markers for retrotransposon (LINE-1) activity** within genomes for evolutionary or genomic studies[3][7]. There is no established direct relationship to disease, drug targeting, or biological pathway involvement for RNU6-297P. If you meant a functional spliceosomal component, the proper target is U6 small nuclear RNA (RNU6-1), but RNU6-297P is a **defunct, non-functional pseudogene** and not a recognized target in pharmacology or molecular therapeutics[4][7].

Other names
RNA, U6 small nuclear 297, pseudogeneRNU6-297P
02

Mechanism of action

None

03

Biological functions

None (no direct biological function; by definition, a pseudogene does not produce functional product)
04

Disease associations

None established (no direct disease role; pseudogenes of snRNAs are mainly studied as genomic markers[3][7])
05

Safety considerations

None known
06

Interacting drugs

None
07

Biomarkers

May serve as genomic markers of retrotransposition activity[3][7]

Beyond the preview

Go deeper on RNA, U6 small nuclear 297, pseudogene (RNU6-297P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 297, pseudogene (RNU6-297P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call